Beta-Blocker Medication: Between Cardiovascular Benefits and Functional Limitations in Medical Rehabilitation
References
- Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017;1:CD002003. doi:10.1002/14651858. CD002003.pub5
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
- Van Baak MA. Beta-adrenergic blockade and exercise: effects on energy metabolism. Med Sci Sports Exerc. 1998;30(3):396–403. doi:10.1097/00005768-199803000-00015
- Bangalore S, Parkar S, Grossman E, Messerli FH. A meta-analysis of randomized trials of beta-blockers on body weight. Am J Med. 2010;123(10):870–876. doi:10.1016/j. amjmed.2010.05.020
- Ades PA, Waldmann ML, Poehlman ET, et al. Hypertension, exercise, and beta-adrenergic blockade. Hypertension. 1988;11(6 Pt 2):II49–II53. doi:10.1161/01.HYP.11.6_ Pt_2.II49
- Briasoulis A, Agarwal V, Messerli FH. Effects of beta-blockers on exercise capacity in physically active patients. Am J Med. 2015;128(9):1042–1049. doi:10.1016/j. amjmed.2015.05.017
- Tabet JY, Meurin P, Teboul F, et al. Determination of exercise training level in coronary artery disease patients on beta blockers. Eur J Cardiovasc Prev Rehabil. 2008;15(1):67–72. doi:10.1097/HJR.0b013e3282f32655
- Fagard RH. Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol. 2002 Jan–Feb;11(1):23–28. PMID:11773712
- Muli S, Meisinger C, Heier M, Thorand B, Peters A, Amann U, et al. Prevalence, awareness, treatment, and control of hypertension in older people: results from the population-based KORA-age 1 study. BMC Public Health. 2020;20:1049. doi:10.1186/s12889-020-09165-8
- Egan B, Flack J, Patel M, Lombera S. Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners. J Clin Hypertens. 2018;20(10):1464–1472. doi:10.1111/jch.13375
- Pischon T, Sharma AM. Use of beta-blockers in obesity hypertension: potential role and metabolic consequences. Int J Obes Relat Metab Disord. 2001;25(10):1477–1481. doi:10.1038/sj.ijo.0801730
- Lamont LS. Beta-blockers and their effects on protein metabolism and resting energy expenditure. J Cardiopulm Rehabil. 1995;15(3):183–185. doi:10.1097/00008483-199505000-00003
- Ramos RA, Ferreira AS. Functional capacity in adults with hypertension as assessed by the six-minute walk distance test: systematic review. Fisioterapia e Pesquisa. 2014;21(3):257–263. doi:10.590/1809-2950/66021032014
- Sheps DS, Bragdon EE, Gray TF 3rd, Ballenger M, Usedom JE, Maixner W. Relation between systemic hypertension and pain perception. Am J Cardiol. 1992 Nov 16;70(16):3F–5F. doi:10.1016/0002-9149(92)90181-W
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
Language: English
Page range: 135 - 140
Published on: Jun 13, 2026
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Lavinia Bodeanu, Liliana-Elena Stanciu, Andreea-Dalila Nedelcu, Andreea-Bianca Uzun, Mădălina-Gabriela Iliescu, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution 4.0 License.